Editors-in-Chief

  • Bryon Petersen, University of Florida
  • Xiangdong Wang, Fudan University

Section Editors

  • Ulf Andersson Ørom, Max Planck Institute for Molecular Genetics
  • Andrew Badley, Mayo Clinic and Foundation
  • Marek Malecki, PBMEF
  • Dan Peer, Tel Aviv University

Articles

There has been an error retrieving the data. Please try again.

Aims & scope

Molecular and Cellular Therapies is an online, open access journal which focusses on the basic science and clinical development of molecular and cell-based therapies.

The journal aligns basic research in the development of gene-, peptide-, protein-, and cell-based therapies with clinical and pre-clinical research, to establish new therapy parameters such as treatment pharmacokinetics, delivery, toxicity, efficacy, biomarkers and novel applications.

Editor profiles

Xiangdong Wang

Xiangdong Wang

Xiangdong Wang, MD, PhD, is a Distinguished Professor of Respiratory Medicine at Fudan University, Deputy Director of Shanghai Respiratory Research Institute, and Adjunct Professor of Clinical Bioinformatics at Lund University. He also serves as a Director of the Biomedical Research Center at Zhongshan Hospital, Fudan University. His main research is focused on clinical bioinformatics, disease-specific biomarkers, cancer immunology, and molecular & cellular therapies.

Bryon Petersen

Bryon Petersen

Dr. Petersen received his BA from the University of Iowa, and received his MS and Ph.D. from the University of Pittsburgh. His post-doctorate training continued at Pitt in the Department of Pathology, and was promoted to Research Assistant Professor. In 2000 Dr. Petersen took a faculty position at the University of Florida as an Assistant Professor and was promoted to an Associate Professor with tenure. In 2010, he took a position at Wake Forest Institute of Regenerative Medicine. He returned to UF's Department of Pediatrics in July of 2012. He currently has authored or co-authored over 80 peer-reviewed papers and nine book chapters. He has been honored with several national and international awards and has secured NIH funding for the past 15 yrs.

Submit a manuscript Sign up for article alerts Contact us Support

Email updates

Receive periodic news and updates relating to BioMed Central straight to your inbox.

ISSN: 2052-8426